Loading ...

Blob

Smart Reasoning:

C&E

See more*

Qaagi - Book of Why

Causes

Effects

2003 Dsu Medical Corp. Tubularsetintravenous

US6616635B1 - Tubular intravenous set - Google Patents Tubularsetintravenous

1].In 20 patients with severe congestive heart failureresultedintravenous milrinone

the environment(passive) may be caused byIntravenous gammaglobulin

to treat conditions such as acute infections , immune deficiencies and auto immune diseases(passive) is designedIntravenous immunoglobulin

Our researchershave accurately createdIntravenous Immunoglobulin

ulnar neuropathy elbowcausesintravenous immunoglobulin

InfusionsetIntravenous cannula

recently(passive) was ... discoveredIntravenous immunoglobin

Treatment with steroids , rituximab , immune cells adsorption , andresultedintravenous immunoglobulins

the HF patients participating in the experimental protocol , as expectedcausedintravenous dobutamine

Different conditionsmay promptintravenous thrombus

The history of trauma , ie , place- insulinoma , relapse of nesidioblastoma , or Addison ’s disease of ment of electrocardiogramleadsintravenous tourniquets

to target an underlying cause of post - operative ileus , the unwanted interaction of opioids with the gastrointestinal tract(passive) is designedIntravenous methylnaltrexone

Dexcosetintravenous

should completedesignedintravenous

to reduce or prevent high uric acid levels in the blood in patients who are undergoing chemotherapy treatment for cancer(passive) is designedIntravenous allopurinol

adherence issues(passive) being caused byintravenous tocilizumab

massive hemoptysispreventedintravenous thrombolysis

We focussedto resultintravenous exudate

The Pain & Anaesthesia Research Centre Personal interests •Mehta VleadsIntravenous parecoxib

The Pain & Anaesthesia Research Centre •Mehta VleadsIntravenous parecoxib

what follows afterinfluencedIntravenous

for the treatment of severe infections which have not been successfully treated with other antibiotics(passive) is only designedIntravenous ) Tigecycline

More long arteries of Signal heartwill leadIntravenous

this afternoon(passive) was setIntravenous

credit aimcan preventintravenous

6515 - 01 - 499 - 0961 extensionsetintravenous admini

Second - line therapy in an emergency departmentsettingIntravenous prochlorperazine

various conditions and variety of microorganisms , including : The most common microorganism that causes osteomyelitis is(passive) can be caused byintravenous

original sale Authors ... movediscoveredintravenous

Some networks of WorldCatwill now triggerintravenous

the actors of an HIV cultivationinventedintravenous

Neither you , nor the methodologies you announced it withwill createintravenous

available vast data , backwards Again as Russia , China , and Japan findto be designedintravenous

Intravenous - health problems 101InventedIntravenous

the practical words describedesignedintravenous

such a reaction which starts predictably within about an hour of treatment and consists of three phases - rigors , flush and defervescence - of the classical “ endotoxin ” or “ shock ” reaction ( Warrell et al ( 1970 ) Clincausesuch a reaction which starts predictably within about an hour of treatment and consists of three phases - rigors , flush and defervescence - of the classical “ endotoxin ” or “ shock ” reaction ( Warrell et al ( 1970 ) Clin

Full Text Nonthrombotic pulmonary embolism(passive) caused byFull Text Nonthrombotic pulmonary embolism

DOI Listing Nonthrombotic pulmonary embolism(passive) caused byDOI Listing Nonthrombotic pulmonary embolism

flow control device * Cited by examinerReferenced byCitingsetflow control device * Cited by examinerReferenced byCiting

in systemic anaphylaxismay resultin systemic anaphylaxis

several serious side effects , including : You may need to stop taking ddI ( see FactSheet 413 ) when you take pentamidinemay also causeseveral serious side effects , including : You may need to stop taking ddI ( see FactSheet 413 ) when you take pentamidine

several serious side effects , including : If your CD4 cell count is below 300 , talk to your health care provider about taking drugs to prevent PCPmay also causeseveral serious side effects , including : If your CD4 cell count is below 300 , talk to your health care provider about taking drugs to prevent PCP

in severe and fatal immune - mediated adverse reactions due to T - cell activation and proliferation that may involve any organ system and manifest during treatment or weeks to months after discontinuationcan resultin severe and fatal immune - mediated adverse reactions due to T - cell activation and proliferation that may involve any organ system and manifest during treatment or weeks to months after discontinuation

Migraine for 3 monthsmay preventMigraine for 3 months

bradycardia , hypotension , and reduced myocardial oxygen consumption ... all serious side effects in an already unstable patientcan causebradycardia , hypotension , and reduced myocardial oxygen consumption ... all serious side effects in an already unstable patient

to clinical improvement of both consciousness and respiration via antagonizing sedation that induced bycan leadto clinical improvement of both consciousness and respiration via antagonizing sedation that induced by

severe side effects and do n't cure the disease or allow people to live longermay causesevere side effects and do n't cure the disease or allow people to live longer

several serious side effects , including : Very high or low blood sugar Problems with the pancreas , liver or kidneys Report any side effects or changes in your condition to your health care provider immediately to avoid serious conditionsmay also causeseveral serious side effects , including : Very high or low blood sugar Problems with the pancreas , liver or kidneys Report any side effects or changes in your condition to your health care provider immediately to avoid serious conditions

several serious side effects , including : Very high or low blood sugar Problems with the pancreas , liver or kidneys High levels of potassium in the blood Irregular heart rhythm Report any side effects or changes in your condition to your health care provider immediately to avoid serious conditionsmay also causeseveral serious side effects , including : Very high or low blood sugar Problems with the pancreas , liver or kidneys High levels of potassium in the blood Irregular heart rhythm Report any side effects or changes in your condition to your health care provider immediately to avoid serious conditions

severe side effects such as nausea and blood disorders ... whereas the inhaled form generally produces nothing more serious than a coughcausessevere side effects such as nausea and blood disorders ... whereas the inhaled form generally produces nothing more serious than a cough

thiamylal - fentanyl - induced bronchoconstriction in humans Department of Anesthesia , Chiba Hokusoh Hospital , Nippon Medical School , Inba gun , Japan Crit Care Med 31:485preventsthiamylal - fentanyl - induced bronchoconstriction in humans Department of Anesthesia , Chiba Hokusoh Hospital , Nippon Medical School , Inba gun , Japan Crit Care Med 31:485

remarkable systematic complications ... presents significant diagnostic difficulties , and also is characterized by a … ( More ) Delayed Airway Obstruction after Internal Jugular Venous Catheterization in a Patient with Anticoagulant Therapy Pei - Ju Wu , Siu - Wah Chau , I - Cheng Lu , Hung - Te Hsu , Kuang ... I Cheng Delayed onset of neck hematoma following central venous catheterization without arterial puncture is uncommonmay causeremarkable systematic complications ... presents significant diagnostic difficulties , and also is characterized by a … ( More ) Delayed Airway Obstruction after Internal Jugular Venous Catheterization in a Patient with Anticoagulant Therapy Pei - Ju Wu , Siu - Wah Chau , I - Cheng Lu , Hung - Te Hsu , Kuang ... I Cheng Delayed onset of neck hematoma following central venous catheterization without arterial puncture is uncommon

an increase in the intracranial pressure and a decrease in the intracranial compliancecausedan increase in the intracranial pressure and a decrease in the intracranial compliance

125I]-IGFresulted125I]-IGF

10 %caused10 %

to a lengthening of bleeding time and inhibition ( slowdown ) of platelet aggregationcan leadto a lengthening of bleeding time and inhibition ( slowdown ) of platelet aggregation

increased adverse side effects [ 81causesincreased adverse side effects [ 81

prolonged bleeding time and inhibition of platelet aggregationcan causeprolonged bleeding time and inhibition of platelet aggregation

further stent migrationpreventedfurther stent migration

skin inflammation at an infusion sitemay causeskin inflammation at an infusion site

an acute , vision - threatening rise in intraocular pressurecan causean acute , vision - threatening rise in intraocular pressure

severe , possibly fatal , intracranial bleeding with neurological deterioration ( in ~2 % of patientscan causesevere , possibly fatal , intracranial bleeding with neurological deterioration ( in ~2 % of patients

in boxsetin box

to mimic field exposuresdesignedto mimic field exposures

in rapid resolution of the polyuria.24resultingin rapid resolution of the polyuria.24

a peak effect at 1 day and no effect at 2 dayscauseda peak effect at 1 day and no effect at 2 days

prolonged hypoglycemiacausedprolonged hypoglycemia

IV Incompatibility Type Intervention Difference in pHcausingIV Incompatibility Type Intervention Difference in pH

to the patient going to the hospital and undergoing a blood analysis , which facilitates obtaining the sample needed in the present studyleadsto the patient going to the hospital and undergoing a blood analysis , which facilitates obtaining the sample needed in the present study

LV microtubule depolymerization in both dogscausedLV microtubule depolymerization in both dogs

a significant increase in the alveolo - arterial oxygen gradientcauseda significant increase in the alveolo - arterial oxygen gradient

further ST - segment elevation in the inferior leads , new ST - segment depression in leads V2-V6 , two distinct forms of premature ventricular complexes ( PVCs ) triggering short runs of polymorphic ventricular tachycardia ( VTcausedfurther ST - segment elevation in the inferior leads , new ST - segment depression in leads V2-V6 , two distinct forms of premature ventricular complexes ( PVCs ) triggering short runs of polymorphic ventricular tachycardia ( VT

severe blood disorders ( e.g. , anemia , bone marrow suppression ) that can result in infection and bleeding problemscan causesevere blood disorders ( e.g. , anemia , bone marrow suppression ) that can result in infection and bleeding problems

hypotension via reduced systemic vascular resistancecan causehypotension via reduced systemic vascular resistance

acute changes in spinal animals as well as alters the enzymecausesacute changes in spinal animals as well as alters the enzyme

Blob

Smart Reasoning:

C&E

See more*